Together these results confirmed our previous findings that editing efficiencies correlated with AAV serotypes and demonstrated that successful editing of the MECP2 gene by AAVHSC editing vectors in Rett syndrome patient-derived cells. The gene discussed is MECP2; the disease is Rett syndrome.